Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias (original) (raw)
References
Hanahan D, Folkman J . Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996 86: 353–364 ArticleCASPubMed Google Scholar
Bergers G, Javaherian K, Lo K-M, Folkman J, Hanahan D . Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 1999 284: 808–812 ArticleCASPubMed Google Scholar
Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J . Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia Am J Pathol 1997 150: 815–821 CASPubMedPubMed Central Google Scholar
Hussong JW, Rodgers GM, Shami PJ . Evidence of increased angiogenesis in patients with acute myeloid leukemia Blood 2000 95: 309–313 CASPubMed Google Scholar
Aguayo A, Estey E, Kantarjian H, Mansouri T, Gidel C, Keating M, Giles F, Estrov Z, Barlogie B, Albitar M . Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 1999 94: 3717–3721 CASPubMed Google Scholar
O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J . Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 1997 88: 277–285 ArticleCASPubMed Google Scholar
Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB . Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity Cancer Res 1999 59: 3433–3441 CASPubMed Google Scholar
Arico M, Biondi A, Pui CH . Juvenile myelomonocytic leukemia Blood 1997 90: 479–488 CASPubMed Google Scholar
Matthes-Martin S, Mann G, Peters C, Lion T, Fritsch G, Haas OA, Potschger U, Gadner H . Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature Bone Marrow Transplant 2000 26: 377–382 ArticleCASPubMed Google Scholar
Iversen PO, Lewis ID, Turczynowicz S, Hasle H, Niemeyer C, Schmiegelow K, Bastiras S, Biondi A, Hughes TP, Lopez AF . Inhibition of granulocyte–macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice Blood 1997 90: 4910–4917 CASPubMed Google Scholar
Bruserud Ø, Tjønnfjord G, Gjertsen BT, Foss B, Ernst P . New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients Stem Cells 2000 18: 343–351 CASPubMed Google Scholar
van Bekkum DW, Hagenbeek A . Relevance of the BN leukemia as a model for human acute myeloid leukemia Blood Cells 1977 3: 565–579 Google Scholar
Martens ACM, van Bekkum DW, Hagenbeek A . The BN acute myelocytic leukemia (BNML) Leukemia 1990 4: 241–257 CASPubMed Google Scholar
Skrede S, Iversen PO . Enhanced oxygen consumption and fatty acid metabolism in rat bone marrow with acute promyelocytic leukaemia Leuk Res 1995 19: 463–467 ArticleCASPubMed Google Scholar
Mortensen BT, Jensen PO, Helledie N, Iversen PO, Ralfkiær E, Larsen JK, Madsen MT . Changing bone marrow microenvironment during development of acute myeloid leukaemia in rats Br J Haematol 1998 102: 458–464 ArticleCASPubMed Google Scholar
Jensen PØ, Mortensen BT, Hodgkiss RJ, Iversen PO, Christensen IJ, Helledie N, Larsen JK . Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukemia in rats Cell Prolif 2000 33: 381–395 ArticleCASPubMed Google Scholar
Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF . Inhibition of proliferation and induction of apoptosis in juvenilemyelomonocytic leukemic cells by the granulocyte–macrophagecolony-stimulating factor analogue E21R Blood 1996 88: 2634–2639 CASPubMed Google Scholar
Sim BKL, Fogler WF, Zhou XH, Liang H, Madsen JW, Luu K, O'Reilly MS, Tomaszewsky JE, Fortier AH . Zinc ligand-disrupted recombinant human endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile Angiogenesis 1999 3: 41–51 ArticleCASPubMed Google Scholar
Martens AC, Johnson RJ, Kaizer H, Hagenbeek A . Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells Exp Hematol 1984 12: 667–671 CASPubMed Google Scholar
Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrøm A, Timpl R, Welsh M, Claesson-Welsh L . Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis Blood 2000 95: 3403–3411 CASPubMed Google Scholar
Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z . Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia Br J Haematol 1992 80: 40–48 ArticleCASPubMed Google Scholar
Hagenbeek A, Martens ACM . High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model Eur J Cancer Clin Oncol 1982 18: 763–769 ArticleCASPubMed Google Scholar
Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, Buchner T, Berdel WE, Mesters RM . Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia Blood 2000 95: 2637–2644 CASPubMed Google Scholar
Musso O, Rehn M, Theret N, Turlin B, Bioulac-Sage P, Lotrian D, Campion JP, Pihlajaniemi T, Clement B . Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas Cancer Res 2001 61: 45–49 CASPubMed Google Scholar
Ratel D, Nasser V, Dupre I, Benabid AL, Berger F . Antibodies to endostatin in a multifocal glioblastoma patient Lancet 2000 356: 1656–1657 ArticleCASPubMed Google Scholar
Kim Y-M, Jang J-W, Lee O-H, Yeon J, Choi EY, Kim KW, Lee ST, Kwon YG . Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2 Cancer Res 2000 60: 5410–5413 CASPubMed Google Scholar
Yamaguchi N, Anand-Apte B, Lee M . Sasaki T, Fukai N, Shapiro R, Que I, Lowick C, Timpl R, Olsen BR. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding EMBO J 1999 18: 4414–4423 ArticleCASPubMedPubMed Central Google Scholar